Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New GHTF (Global Harmonization Task Force) clinical evidence working group makes speedy progress

This article was originally published in Clinica

Executive Summary

Considerable progress has been made by the new Global Harmonization Task Force (GHTF)working group dealing with clinical evidence, since its inaugural meeting on January 17-18. Study group 5 has the aim of ultimately harmonising principles to determine when a clinical investigation, as opposed to other forms of clinical evidence, is needed, an issue of key concern globally, and particularly in the EU at present. According to the minutes of the May 9-10 meeting in London, UK, just posted on the GHTF website, members of SG5 had successfully spent the intervening five months: researching the existence of any differences in key definitions in terms used in the area of clinical evidence in documents worldwide, with an aim of drawing up new, harmonised global definitions; considering the overlap between its work and that being conducted in the context of clinical evaluation standards; and developing draft guidance on clinical evaluation.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT055672

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel